Related Articles
High levels of DEPDC1B predict shorter biochemical recurrence‑free survival of patients with prostate cancer
Eukaryotic translation initiation factor 5A2 is highly expressed in prostate cancer and predicts poor prognosis
Combinations of elevated tissue miRNA‑17‑92 cluster expression and serum prostate‑specific antigen as potential diagnostic biomarkers for prostate cancer
Enhanced expression of centromere protein F predicts clinical progression and prognosis in patients with prostate cancer
Association of molecular biomarkers expression with biochemical recurrence in prostate cancer through tissue microarray immunostaining